Vision and hearing during deferoxamine therapy
Open Access
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 117 (2) , 326-330
- https://doi.org/10.1016/s0022-3476(05)80556-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosageBritish Journal of Haematology, 1989
- Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?British Journal of Ophthalmology, 1989
- Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.Archives of Disease in Childhood, 1988
- Hearing Loss and Desferrioxamine in Homozygous Beta-ThalassemiaInternational Journal of Audiology, 1988
- Ocular Toxicity after a Single Intravenous Dose of Desferrioxamine in 2 Hemodialyzed PatientsNephron, 1987
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- ACUTE DEAFNESS AND DESFERRIOXAMINEThe Lancet, 1985
- VISUAL LOSS IN PATIENT ON HIGH-DOSE SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1984
- DESFERRIOXAMINE, OCULAR TOXICITY, AND TRACE METALSThe Lancet, 1983
- Auditory Involvement in Thalassemia MajorActa Haematologica, 1979